Page last updated: 2024-08-17

cytidine monophosphate and Myelodysplastic Syndromes

cytidine monophosphate has been researched along with Myelodysplastic Syndromes in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.14)18.7374
1990's12 (85.71)18.2507
2000's0 (0.00)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatta, Y; Hirabayashi, Y; Horikoshi, A; Iriyama, N; Kobayashi, S; Kodaira, H; Matsukawa, Y; Miura, K; Takahashi, H; Takeuchi, J; Uchino, Y1
Arimori, K; Fujiwara, H; Fukuda, R; Kawada, H; Masumoto, A; Ogawa, Y; Ohbayashi, Y; Sasao, T; Umeda, Y; Watanabe, S1
Arie, Y; Hirai, M; Kikukawa, M; Kodo, H; Kumakawa, T; Mizutani, R; Mori, M; Murai, Y; Nakamura, N; Tsutsumi, H1
Mori, N; Murakami, S; Nagata, K; Nakanishi, M; Nakata, K; Ogawa, R; Serino, Y; Takazawa, A; Tonai, S; Wake, A1
Arai, T; Araki, M; Hayakawa, K; Narimiya, S; Shibuya, C; Takaya, T; Toshima, S; Uchida, A; Yasuda, Y; Yoshimi, N1
Andoh, K; Fujimoto, H; Funasako, M; Hata, N; Itoh, K; Itoh, Y; Nakai, S; Nishi, T; Ohata, M; Ono, H; Sato, H; Sato, Y; Taniji, M; Ueda, A1
Chuhjo, T; Katoh, T; Kaya, H; Matano, S; Matsuda, T; Murashima, M; Nakamura, S; Ohtake, S; Okumura, H; Takamatsu, H; Takeshima, M; Watanabe, A; Yamauchi, H; Yoshida, T1
Ito, T; Konishi, H; Maesako, Y; Mori, S; Ueda, Y; Yagiri, Y1
Hirano, M; Imai, K; Kosaka, M; Mizoguchi, H; Nakamura, T; Ohno, R; Takatsuki, K; Tatsumi, N; Toyama, K; Yamaya, T1
Furukawa, Y; Hiyoshi, M; Im, T; Inoue, K; Kishida, T; Nakao, Y; Ohira, H; Ota, K; Yamane, T; Yasui, Y1
Fukuoka, M; Hattori, M; Hirota, Y; Miyazaki, T; Nakamura, T; Niitani, H; Ohta, K; Suzuoki, Y; Tanaka, M; Yoshida, Y1
Kimura, I; Kimura, K; Masaoka, T; Nakamura, T; Ohno, R; Ohshima, T; Tatsumi, N; Yamada, K1
Imamura, S; Kamiya, K; Kawai, Y; Nakamura, T; Tsutani, H; Ueda, T; Wano, Y1
Kamiya, K; Nakamura, T; Sugiyama, M; Tanaka, T; Tsutani, H; Ueda, T; Wano, Y1

Trials

5 trial(s) available for cytidine monophosphate and Myelodysplastic Syndromes

ArticleYear
Treatment of acute myeloid leukemia and myelodysplastic syndrome with orally administered cytarabine ocfosfate and granulocyte colony-stimulating factor.
    International journal of hematology, 1997, Volume: 65, Issue:3

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes

1997
[A pharmacokinetic study of the value of oral cytarabine ocfosfate in the treatment of hematological malignancies].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:5

    Topics: Administration, Oral; Aged; Antineoplastic Agents; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Time Factors

1998
Treatment of myelodysplastic syndromes with orally administered 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate.
    Oncology, 1991, Volume: 48, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Arabinonucleotides; Cytidine Monophosphate; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes

1991
[Phase I study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:11

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Diarrhea; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Middle Aged; Myelodysplastic Syndromes; Nausea; Vomiting

1990
[Phase II study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) on hematological malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:12

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Drug Administration Schedule; Drug Evaluation; Female; Humans; Japan; Leukemia; Male; Middle Aged; Myelodysplastic Syndromes; Nausea; Remission Induction; Vomiting

1990

Other Studies

9 other study(ies) available for cytidine monophosphate and Myelodysplastic Syndromes

ArticleYear
Efficacy of oral cytarabine ocfosfate and etoposide in the treatment of elderly patients with higher-risk myelodysplastic syndromes compared to that in elderly acute myeloid leukemia patients.
    Chemotherapy, 2013, Volume: 59, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Disease-Free Survival; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Treatment Outcome

2013
[Effects of cytarabine ocfosfate on colony-stimulating factor in myelodysplastic syndrome with monosomy 7].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1994, Volume: 35, Issue:6

    Topics: Adult; Arabinonucleotides; Chromosomes, Human, Pair 7; Cytidine Monophosphate; Drug Resistance; Granulocyte Colony-Stimulating Factor; Humans; Karyotyping; Leukocyte Count; Male; Monosomy; Myelodysplastic Syndromes

1994
[Plasma concentration of cytosine arabinoside (Ara-C) in the elderly patients with hematological malignancy treated by Ara-C or cytarabine ocfosfate (SPAC)].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1995, Volume: 32, Issue:3

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes

1995
[Successful treatment of acute myelomonocytic leukemia developed from MDS with cytarabine ocfosfate (SPAC)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:3

    Topics: Aged; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Drug Administration Schedule; Female; Humans; Leukemia, Myelomonocytic, Acute; Myelodysplastic Syndromes; Remission Induction

1995
[Successful treatment of myelodysplastic syndrome with cytarabine ocfosfate].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:7

    Topics: Aged; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Humans; Male; Myelodysplastic Syndromes; Remission Induction

1994
[Five cases of myelodysplastic syndrome treated with cytarabine ocfosfate].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:10

    Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction

1996
[Clinical effects of stearyl-ara-CMP (YNK-01) on chronic hematologic malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Arabinonucleotides; Chronic Disease; Cytidine Monophosphate; Drug Evaluation; Female; Humans; Leukemia; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Remission Induction

1991
Successful treatment of myelodysplastic syndrome with 1-beta-D-arabinofuranosylcytosine 5'-stearylphosphate.
    Leukemia research, 1990, Volume: 14, Issue:11-12

    Topics: Aged; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction

1990
[Pharmacokinetics of stearyl-ara-CMP (YNK-01) in patients with hematologic neoplasms].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:9

    Topics: Acute Disease; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Cytosine Nucleotides; Drug Evaluation; Humans; Leukemia; Myelodysplastic Syndromes

1989